Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer

Journal of Clinical Oncology

Volumn 11, Issue 5, 1993, Pages 909-913

  Shimada, Y ^a   Yoshino, M ^a   Wakui, A ^a   Nakao, I ^a   Futatsuki, K ^a   Sakata, Y ^a   Kambe, M ^a   Taguchi, T ^a   Ogawa, N ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IRINOTECAN;

ADULT; AGED; ALOPECIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; COLORECTAL CANCER; DRUG RESPONSE; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0027194943     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1993.11.5.909     Document Type: Article

References (0)